Morgan Stanley Sticks to Their Hold Rating for Galapagos (GLPG)
In a report released today, Judah Frommer from Morgan Stanley maintained a Hold rating on Galapagos (GLPG – Research Report), with a price ...
TD Cowen Downgrades Galapagos (NASDAQ:GLPG) to Strong Sell
TD Cowen cut shares of Galapagos (NASDAQ:GLPG – Free Report) from a strong-buy rating to a strong sell rating in a report released on Thursday,Zacks.com reports. Other equities analysts also recently ...
Galapagos Underperform Rating: Strategic Uncertainties and Financial Challenges
Bank of America Securities analyst Jason Gerberry maintained a Sell rating on Galapagos (GLPG – Research Report) today and set a price target ...
Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
Galapagos NV plans to split into two entities by mid-2025, focusing on oncology cell therapy and innovative medicines, with ...
Hosted on MSN6d
Galapagos Stock Surges On Strategic Spin-Off And Restructuring Plans: Retail Turns Extremely Bullish
U.S.-listed shares rose over 4% in Wednesday's premarket after it announced a significant restructuring plan, including a ...
The Pharma Letter6d
Galapagos split in two, fires 40% of workforce
Galapagos plans to split into two entities by mid-2025, focusing its core business on cell therapies while spinning off a new ...
Galapagos to amend Gilead deal; to spin off innovative medicines unit
Galapagos (GLPG) stock is in focus as the company looks to amend its 10-year deal with Gilead (GILD) as part of plans to ...
PharmiWeb6d
Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 1:30 pm PT in San Francisco ...
Galapagos NV: Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities
Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines through transformational transactions Galapagos will gain ...
Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities
Galapagos intends to create a new company with approximately €2.45 billion in cash dedicated to building a pipeline of innovative medicines through transformational transactions Galapagos will gain ...